CN105169134A - Medicament for treating lymphadenectasis - Google Patents

Medicament for treating lymphadenectasis Download PDF

Info

Publication number
CN105169134A
CN105169134A CN201510672524.XA CN201510672524A CN105169134A CN 105169134 A CN105169134 A CN 105169134A CN 201510672524 A CN201510672524 A CN 201510672524A CN 105169134 A CN105169134 A CN 105169134A
Authority
CN
China
Prior art keywords
parts
component
fructus
weight
lymphadenectasis
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201510672524.XA
Other languages
Chinese (zh)
Inventor
陈秀梅
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN201510672524.XA priority Critical patent/CN105169134A/en
Publication of CN105169134A publication Critical patent/CN105169134A/en
Pending legal-status Critical Current

Links

Landscapes

  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a medicament for treating lymphadenectasis. The medicament comprises a component A and a component B, wherein the component A is prepared from the following raw materials in part by weight: 8 to 15 parts of glabrous greenbrier rhizome, 5 to 8 parts of honeysuckle, 10 to 20 parts of fructus forsythia, 9 to 14 parts of stir-baked squama manitis, 6 to 12 parts of coptis chinensis, 4 to 10 parts of licorice root, 10 to 22 parts of seaweed and 9 to 18 parts of kelp; the component B is prepared from the following raw materials in part by weight: 14 to 35 parts of cocklebur fruit, 20 to 45 parts of puberulous glochidion herb, 22 to 42 parts of myrtle, 26 to 45 parts of abutilon indicum sweet and 200 to 300 parts of small intestine of pig. The medicament is administrated by combining two different components, is used for treating lymph node, and has the advantages of no toxic or side effect, good treatment effect and quick curative effect.

Description

A kind of medicine for the treatment of lymphadenectasis
[technical field]
The invention belongs to drug world, be specifically related to a kind of medicine for the treatment of lymphadenectasis.
[background technology]
Lymph node (Lymphnode) is the distinctive organ of mammal (aquatic bird also has two pairs of lymph nodes).Normal person's superficial lymph knot is very little, and diameter is many within 0.5 centimetre, smooth surface, softness, with surrounding tissue without adhesion, also without tenderness.When antibacterial enters body from injury, lymphocyte can produce lymphokine and antibody kill bacteria effectively.Result is lymph node endolymph biological cells and tissues cellular responsibility hypertrophy, makes lymphadenectasis, is called reactive hyperplasia of lymph node.What can cause reactive hyperplasia of lymph node also has virus, some chemicals, the toxic product of metabolism, the component of organization of degeneration and foreign body etc.Therefore, the lymph node of enlargement is the beacon tower of human body, it is an alarm device, if can not get timely treatment, local red and swollen heat pain will be caused, and normal with symptoms such as fear of cold heating, headaches, by anti-inflammation treatment timely, redness can disappear, but sometimes because inflammation causes hamartoplasia, can leave over a little scleroma.If inflammation fails to control in time, be diffused into lymph node and adhesion mutually, severe patient can form abscess.But nowadays and have the medicine for the treatment of lymphadenectasis etc.
[summary of the invention]
For the problems referred to above, the invention provides a kind of medicine for the treatment of lymphadenectasis, for treating because of lymphadenectasis, inflammation etc.
The present invention is achieved by the following technical solutions, and provide a kind of medicine for the treatment of lymphadenectasis, comprise component A and B component, the raw material of described component A is calculated by weight, and comprises following component:
Rhizoma Smilacis Glabrae 8 ~ 15 parts, Flos Lonicerae 5 ~ 8 parts, Fructus Forsythiae 10 ~ 20 parts, stir-baked SQUAMA MANITIS 9 ~ 14 parts, Rhizoma Coptidis 6 ~ 12 parts, 4 ~ 10 parts, Radix Glycyrrhizae, Sargassum 10 ~ 22 parts, Thallus Laminariae (Thallus Eckloniae) 9 ~ 18 parts;
The raw material of described B component calculates by weight, comprises following component:
Fructus Xanthii 14 ~ 35 parts, Fructus glochidionis puberi(Herba Glochidii Puberi) 20 ~ 45 parts, Fructus Rhodomyrti 22 ~ 42 parts, Herba abutili indici 26 ~ 45 parts, pig small intestine 200 ~ 300 parts.
Especially, comprise component A and B component, the raw material of described component A is calculated by weight, and comprises following component:
Rhizoma Smilacis Glabrae 10 parts, Flos Lonicerae 8 parts, Fructus Forsythiae 15 parts, stir-baked SQUAMA MANITIS 10 parts, Rhizoma Coptidis 8 parts, 6 parts, Radix Glycyrrhizae, Sargassum 15 parts, Thallus Laminariae (Thallus Eckloniae) 15 parts;
The raw material of described B component calculates by weight, comprises following component:
Fructus Xanthii 20 parts, Fructus glochidionis puberi(Herba Glochidii Puberi) 30 parts, Fructus Rhodomyrti 30 parts, Herba abutili indici 30 parts, pig small intestine 250 parts.
The manufacture method of instant component A is:
Rhizoma Smilacis Glabrae, Flos Lonicerae, Fructus Forsythiae, stir-baked SQUAMA MANITIS, Rhizoma Coptidis, Radix Glycyrrhizae, Sargassum, Thallus Laminariae (Thallus Eckloniae) are put into medicine kettle, adds 3 parts of water afterwards and boil, when the water in medicine kettle only remains a, filter and obtain medicinal liquid one; Add two parts of water afterwards to proceed to boil, when the water in medicine kettle only remains moiety, filter and obtain medicinal liquid two, medicinal liquid two and medicinal liquid one are merged, obtain component A medicinal liquid;
The manufacture method of instant component B is:
Fructus Xanthii, Fructus glochidionis puberi(Herba Glochidii Puberi), Fructus Rhodomyrti, Herba abutili indici are put into medicine kettle, adds 3 parts of water afterwards and boil, when the water in medicine kettle only remains a, filter and obtain medicinal liquid one; Add two parts of water afterwards to proceed to boil, when the water in medicine kettle only remains moiety, filter and obtain medicinal liquid two, medicinal liquid two and medicinal liquid one are merged, obtain B component medicinal liquid, by ripe for pig small intestine steaming and decocting.
Instructions of taking:
Component A medicinal liquid is divided into two parts by first day, takes night and morning; B component medicinal liquid and pig small intestine are divided into two parts respectively in second day, sooner or later respectively take portion; Intersection like this is taken, and after taking 10-20 days continuously, disease obtains medical treatment.
Compared to prior art, a kind of medicine for the treatment of lymphadenectasis provided by the invention, is combined by the medicine of two kinds of different components and takes, treat lymph node, this medicine have have no side effect, therapeutic effect is good, curative effect is fast advantage.
[detailed description of the invention]
In order to make object of the present invention, technical scheme and advantage clearly understand, below in conjunction with embodiment, the present invention is described in more detail.
Embodiment 1
Treat a medicine for lymphadenectasis, comprise component A and B component, the raw material of described component A is calculated by weight, and comprises following component:
Rhizoma Smilacis Glabrae 10 parts, Flos Lonicerae 8 parts, Fructus Forsythiae 15 parts, stir-baked SQUAMA MANITIS 10 parts, Rhizoma Coptidis 8 parts, 6 parts, Radix Glycyrrhizae, Sargassum 15 parts, Thallus Laminariae (Thallus Eckloniae) 15 parts;
The raw material of described B component calculates by weight, comprises following component:
Fructus Xanthii 20 parts, Fructus glochidionis puberi(Herba Glochidii Puberi) 30 parts, Fructus Rhodomyrti 30 parts, Herba abutili indici 30 parts, pig small intestine 250 parts.
The manufacture method of instant component A is:
Rhizoma Smilacis Glabrae, Flos Lonicerae, Fructus Forsythiae, stir-baked SQUAMA MANITIS, Rhizoma Coptidis, Radix Glycyrrhizae, Sargassum, Thallus Laminariae (Thallus Eckloniae) are put into medicine kettle, adds 3 parts of water afterwards and boil, when the water in medicine kettle only remains a, filter and obtain medicinal liquid one; Add two parts of water afterwards to proceed to boil, when the water in medicine kettle only remains moiety, filter and obtain medicinal liquid two, medicinal liquid two and medicinal liquid one are merged, obtain component A medicinal liquid;
The manufacture method of instant component B is:
Mountain Rhizoma Solani tuber osi head, Fructus Xanthii, Fructus glochidionis puberi(Herba Glochidii Puberi), Fructus Rhodomyrti, Herba abutili indici are put into medicine kettle, adds 3 parts of water afterwards and boil, when the water in medicine kettle only remains a, filter and obtain medicinal liquid one; Add two parts of water afterwards to proceed to boil, when the water in medicine kettle only remains moiety, filter and obtain medicinal liquid two, medicinal liquid two and medicinal liquid one are merged, obtain B component medicinal liquid, by ripe for pig small intestine steaming and decocting.
Instructions of taking:
Component A medicinal liquid is divided into two parts by first day, takes night and morning; B component medicinal liquid and pig small intestine are divided into two parts respectively in second day, sooner or later respectively take portion; Intersection like this is taken, and after taking 10-40 days continuously, disease obtains medical treatment.
Embodiment 2
Treat a medicine for lymphadenectasis, comprise component A and B component, the raw material of described component A is calculated by weight, and comprises following component:
Rhizoma Smilacis Glabrae 8 parts, Flos Lonicerae 12 parts, Fructus Forsythiae 10 parts, stir-baked SQUAMA MANITIS 14 parts, Rhizoma Coptidis 6 parts, 10 parts, Radix Glycyrrhizae, Sargassum 10 parts, Thallus Laminariae (Thallus Eckloniae) 18 parts;
The raw material of described B component calculates by weight, comprises following component:
Fructus Xanthii 35 parts, Fructus glochidionis puberi(Herba Glochidii Puberi) 20 parts, Fructus Rhodomyrti 42 parts, Herba abutili indici 26 parts, pig small intestine 300 parts.
Preparation method is identical with embodiment 1 with instructions of taking, repeats no more herein.
Embodiment 3
Treat a medicine for lymphadenectasis, comprise component A and B component, the raw material of described component A is calculated by weight, and comprises following component:
Rhizoma Smilacis Glabrae 15 parts, Flos Lonicerae 6 parts, Fructus Forsythiae 20 parts, stir-baked SQUAMA MANITIS 9 parts, Rhizoma Coptidis 12 parts, 4 parts, Radix Glycyrrhizae, Sargassum 22 parts, Thallus Laminariae (Thallus Eckloniae) 9 parts;
The raw material of described B component calculates by weight, comprises following component:
Fructus Xanthii 14 parts, Fructus glochidionis puberi(Herba Glochidii Puberi) 45 parts, Fructus Rhodomyrti 22 parts, Herba abutili indici 45 parts, pig small intestine 200 parts.
Preparation method is identical with embodiment 1 with instructions of taking, repeats no more herein.
Embodiment 4
Treat a medicine for lymphadenectasis, comprise component A and B component, the raw material of described component A is calculated by weight, and comprises following component:
Rhizoma Smilacis Glabrae 12 parts, Flos Lonicerae 9 parts, Fructus Forsythiae 13 parts, stir-baked SQUAMA MANITIS 11 parts, Rhizoma Coptidis 9 parts, 8 parts, Radix Glycyrrhizae, Sargassum 18 parts, Thallus Laminariae (Thallus Eckloniae) 12 parts;
The raw material of described B component calculates by weight, comprises following component:
Fructus Xanthii 24 parts, Fructus glochidionis puberi(Herba Glochidii Puberi) 25 parts, Fructus Rhodomyrti 26 parts, Herba abutili indici 34 parts, pig small intestine 220 parts.
Preparation method is identical with embodiment 1 with instructions of taking, repeats no more herein.
Embodiment 5
Treat a medicine for lymphadenectasis, comprise component A and B component, the raw material of described component A is calculated by weight, and comprises following component:
Rhizoma Smilacis Glabrae 14 parts, Flos Lonicerae 10 parts, Fructus Forsythiae 18 parts, stir-baked SQUAMA MANITIS 12 parts, Rhizoma Coptidis 10 parts, 9 parts, Radix Glycyrrhizae, Sargassum 20 parts, Thallus Laminariae (Thallus Eckloniae) 13 parts;
The raw material of described B component calculates by weight, comprises following component: 25 ~ 40 parts, mountain Rhizoma Solani tuber osi head, Fructus Xanthii 20 parts, Fructus glochidionis puberi(Herba Glochidii Puberi) 40 parts, Fructus Rhodomyrti 35 parts, Herba abutili indici 40 parts, pig small intestine 280 parts.
Preparation method is identical with embodiment 1 with instructions of taking, repeats no more herein.
Should be understood that, in those skilled in the art, can be improved according to the above description or convert, and all these improve and convert the protection domain that all should belong to claims of the present invention.

Claims (2)

1. treat a medicine for lymphadenectasis, it is characterized in that, comprise component A and B component, the raw material of described component A is calculated by weight, composed of the following components:
Rhizoma Smilacis Glabrae 8 ~ 15 parts, Flos Lonicerae 5 ~ 8 parts, Fructus Forsythiae 10 ~ 20 parts, stir-baked SQUAMA MANITIS 9 ~ 14 parts, Rhizoma Coptidis 6 ~ 12 parts, 4 ~ 10 parts, Radix Glycyrrhizae, Sargassum 10 ~ 22 parts, Thallus Laminariae (Thallus Eckloniae) 9 ~ 18 parts;
The raw material of described B component calculates by weight, composed of the following components:
Fructus Xanthii 14 ~ 35 parts, Fructus glochidionis puberi(Herba Glochidii Puberi) 20 ~ 45 parts, Fructus Rhodomyrti 22 ~ 42 parts, Herba abutili indici 26 ~ 45 parts, pig small intestine 200 ~ 300 parts.
2. a kind of medicine for the treatment of lymphadenectasis according to claim 1, is characterized in that, comprise component A and B component, the raw material of described component A is calculated by weight, composed of the following components:
Rhizoma Smilacis Glabrae 10 parts, Flos Lonicerae 8 parts, Fructus Forsythiae 15 parts, stir-baked SQUAMA MANITIS 10 parts, Rhizoma Coptidis 8 parts, 6 parts, Radix Glycyrrhizae, Sargassum 15 parts, Thallus Laminariae (Thallus Eckloniae) 15 parts;
The raw material of described B component calculates by weight, composed of the following components:
Fructus Xanthii 20 parts, Fructus glochidionis puberi(Herba Glochidii Puberi) 30 parts, Fructus Rhodomyrti 30 parts, Herba abutili indici 30 parts, pig small intestine 250 parts.
CN201510672524.XA 2015-10-19 2015-10-19 Medicament for treating lymphadenectasis Pending CN105169134A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201510672524.XA CN105169134A (en) 2015-10-19 2015-10-19 Medicament for treating lymphadenectasis

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201510672524.XA CN105169134A (en) 2015-10-19 2015-10-19 Medicament for treating lymphadenectasis

Publications (1)

Publication Number Publication Date
CN105169134A true CN105169134A (en) 2015-12-23

Family

ID=54891882

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201510672524.XA Pending CN105169134A (en) 2015-10-19 2015-10-19 Medicament for treating lymphadenectasis

Country Status (1)

Country Link
CN (1) CN105169134A (en)

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007238559A (en) * 2006-03-10 2007-09-20 Nagoya City Univ Immature dendritic cell-activating agent and use thereof
CN101744963A (en) * 2008-12-15 2010-06-23 张龙 Traditional Chinese medicine preparation for detumescence by detoxification

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2007238559A (en) * 2006-03-10 2007-09-20 Nagoya City Univ Immature dendritic cell-activating agent and use thereof
CN101744963A (en) * 2008-12-15 2010-06-23 张龙 Traditional Chinese medicine preparation for detumescence by detoxification

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
土荣华等: "《小偏方 大健康》", 31 August 2011 *

Similar Documents

Publication Publication Date Title
CN102961729B (en) Externally-used traditional Chinese medicine for treating varicosity, thromboangiitis obliterans and phlebitis
CN104547386A (en) Hemorrhoids ointment
CN104740202A (en) Medicine for treating skin itch
CN102100872A (en) Chinese medicine preparation for treating mastitis
CN104547188A (en) External preparation for treating varicosity and preparation method thereof
CN104043022A (en) Traditional Chinese medicine composition for treating gynecologic inflammation
CN101181475B (en) Chinese medicine composition orally taken for curing acute eczema
CN104547599A (en) Traditional Chinese medicine composition for treating kidney yang deficiency type chronic cervicitis and preparation method thereof
CN104758726A (en) Traditional Chinese medicine composition for treating urinary tract infection
CN104107335A (en) Traditional Chinese medicine composition for oral administration and external application for treating canker sore
CN104587312A (en) Traditional Chinese medicine composition for treating constipation
CN104258236A (en) Traditional Chinese medicine composition for nursing vaginas of women in puerperium
CN104069355A (en) Medicinal composition for treating rheumatic arthritis and rheumatoid arthritis
CN105596769A (en) Traditional Chinese medicine for treating scalds, bedsores and hemorrhoid
CN105169134A (en) Medicament for treating lymphadenectasis
CN103127411B (en) Traditional Chinese medicine used for treating urinary tract infection disease
CN101647957A (en) Medicament for treating scald
CN104825617A (en) Traditional Chinese medicine for treating rheumatism bone disease and traditional Chinese medicine bag
CN104606624A (en) Traditional-Chinese-medicine composition for treating dampness and heat of liver and gallbladder
CN105878509A (en) Preparation method of traditional Chinese medicine liquid for treating pruritic scrotal eczema
CN103845610A (en) Medicament for treating prostatitis
CN103961656B (en) A kind of Chinese medicine treating Chronic venous insufficiency
CN102940814B (en) Medicine for treating tubal nowhere
CN105497727A (en) Constipation treating traditional Chinese medicine composition
CN104474270A (en) Traditional Chinese medicine composition and application thereof

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
WD01 Invention patent application deemed withdrawn after publication

Application publication date: 20151223

WD01 Invention patent application deemed withdrawn after publication